The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2015Cell-to-Cell Transport of Alpha-Synuclein
Study Rationale:
In Parkinson’s disease, the protein alpha-synuclein changes shape, and we think it transfers around the brain. We want to see if we can recreate this in non-human... -
Research Grant, 2015Selective mGluR3 Positive Allosteric Modulators as Neuroprotective Agents for Parkinson's Disease Supplement
Study Rationale:
mGluR3 is a novel target leading to neuroprotection through production of neurotrophic factors. We have recently demonstrated that selective mGluR3 positive... -
Research Grant, 2015Pre-clinical Evaluation of Neuroprotective Small Molecule Erythropoietin Receptor Agonists in the Treatment of Parkinson’s Disease Supplement
Study Rationale:
STATegics has discovered small molecules that selectively activate the tissue-protective erythropoietin (EPO) receptor, but not the EPO receptor that plays a role in... -
Therapeutic Pipeline Program, 2015GAITPARK_ATLAS: Finding New Targets to Treat Gait and Balance Disorders in Parkinson’s Disease
Study Rationale:
Gait and balance disorders are the primary motor disability in advanced Parkinson’s disease (PD). These disorders arise in part due to dysfunction of the lateral... -
Research Grant Supplement, 2015Parc (a Parkin-related E3 ligase): Functions in Neuronal Survival and Parkinson’s Disease Supplement
Promising Outcomes of Original Grant:
Our research had identified a Parkin-related protein, called Parc, to be important for neuronal survival in situations of mitochondrial injury. Specifically, we... -
Improved Biomarkers and Clinical Outcome Measures, 2015Measuring Altered White Blood Cell Functionality as a Biomarker of Parkinson’s Disease
Study Rationale:
White blood cells from people with Parkinson’s disease (PD) patients appear to differ from those of control individuals in that there are differences in the set of genes that are...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.